number of substances have been proposed to play a role in the development of cerebral vasospasm after subarachnoid hemorrhage. The weight of evidence suggests that the primary agents are derived from the hematoma itself1 and from the red blood cell in particular.2'3 In addition to extensive documentation of the vasoactivity of oxyhemoglobin,4-7 several reports have indicated that bilirubin, a hemoglobin breakdown product, is capable of producing constriction of cerebral arteries, both in vivo and in vitro. 4, 8, 9 One part of this study was undertaken to determine the levels of bilirubin in subarachnoid clot. The remainder of the study focused on the mechanisms of bilirubin-induced vasocontraction. In principle, bilirubin could act (1) directly on the smooth muscle cells; (2) indirectly, by eliciting the release of vasoactive substances from nerve varicosities in the adventitia; and/or (3) also indirectly, through the release of similar types of substances from endothelial cells. In this report we investigated the first possibility by studying the effects of bilirubin on the morphology and the calcium ion uptake of arterial smooth muscle cells. The effects of Ca2`-free media and of a calcium channel blocker were also investigated. The For the aforementioned experiments, bilirubin solutions were prepared by dissolving crystalline bilirubin (Sigma Chemical Co, St Louis, Mo) in 0.01N NaOH, which was then diluted with distilled water to achieve the desired final concentration. Twenty-five microliters of this solution was added to 1 mL of cellular suspensions. The same amount of NaOH solution without bilirubin was used for control measurements. Experiments were carried out under dark conditions to minimize photoisomerization and oxidation of bilirubin.
All procedures for the isolation and primary culture of basilar artery smooth muscle cells were performed under aseptic conditions. The basilar artery was resected from adult mongrel dogs under general anesthesia. The artery was cleaned of connective tissue and adventitia in M199 containing 25 mmol/L HEPES, 100 U/mL penicillin, and 100 ,g/mL streptomycin. The arteries were opened longitudinally, and the intimal surface was gently scraped with a scalpel blade to remove the endothelium. The arteries were then minced into 1-mm squares and digested in M199 containing 25 mmol/L HEPES, collagenase class II (600 U/mL), elastase type III (50 U/mL), soybean trypsin inhibitor (0.1%), bovine serum albumin (1.5%), animo acid standard (1.3%), ATP (4.0 mmol/L), and penicillin and streptomycin as above, at 37°C for 1 hour in a shaker bath. After spontaneous settling of the digested debris, the supernatant cell suspension was carefully collected with a pipette and centrifuged at 1000 rpm for 3 minutes. The cell pellet was resuspended in M199 supplemented with 10% fetal calf serum, 25 mmol/L HEPES, and the aforementioned antibiotics and then seeded in plastic culture flasks. These cells were reacted with mouse monoclonal anti-a-actin smooth muscle cell antibody (Sigma), then with biotinylated horse antimouse immunoglobulin antibody, and finally with avidin DH and biotinylated horseradish peroxidase H. 3,3'Diaminobenzidine was used as the chromophore. These cells stained positively for a-actin, whereas similar cells in which the initial step with anti-a-actin antibody had been omitted did not. After reaching confluency the cells were seeded at an initial density of 2x 104 cells per dish. The medium was changed to serum-free medium 2 days after seeding. Bilirubin first dissolved in 0.1 N NaOH, and serum albumin (Sigma) were then added to achieve a final concentration of 50 ,umol/L bilirubin and a molar ratio of bilirubin to albumin of 1.5:1.0. The same amount of NaOH and of albumin without bilirubin was added to control cells. Dishes of cells were fixed with 2.5% glutaraldehyde in situ at 0, 24, and 48 hours. The length of 50 consecutive cells from each dish of cells was measured as described previously. To examine further the cause of these changes, we asked the following questions. (1) Was the increased Ca'2 uptake induced by bilirubin due to greater Ca 2+ binding, perhaps to membrane-bound bilirubin, or was it due to an increased permeability? (2) Did other solutes show a similar increase in uptake? To address these questions it was necessary to use cells that were completely depleted of ATP to eliminate energy-dependent ion movements but that still had an intact plasma membrane. We used this system because this state was well defined in previous studies in one of our laboratories using isolated adult rat heart cells.14 Fig 5 shows that bilirubin increased the uptake of Ca'2, but no increased permeation of sucrose was detected. The Ca7+ ionophore A23187 further increased the extent of Ca' uptake. Bilirubin, however, did not affect the final level of Ca-+ uptake after A23187.
Discussion
The primary findings of this study are that bilirubin accrues in subarachnoid hematoma and that it produces a direct contractile effect on arterial smooth muscle cells.
Although it has long been recognized that the xanthochromia of cerebrospinal fluid after subarachnoid hemorrhage is primarily due to the presence of bilirubin, the development of significant levels of this substance in hematoma has recently been questioned. 1617 One group of investigators has reported that no or minimal bilirubin was recovered from agar that had been soaked with hemoglobin and deposited in the subarachnoid compartment of monkeys. 6 Second, because bilirubin is known to bind Ca2+,30 it was important to determine whether the increased uptake was due to binding of the ion to membranebound bilirubin or to a change in permeability. The results with heart cells suggest that the effects of bilirubin on Ca 2+ uptake are not caused by an increase in Ca2' binding, since such an increase would be expected to remain after A23187 treatment. It appears, therefore, that the effect of bilirubin is to increase membrane permeability. The evidence that bilirubin increases the permeability of the membrane to Ca21
explains not only the increased uptake but also the morphological changes induced by bilirubin, since these cells are known to contract in response to increased levels of intracellular Ca2+. 31 Further, this increased permeability does not appear to be nonspecific, inasmuch as the permeability to sucrose did not increase. Although these findings could be limited to cardiac myocytes, it is also possible that they apply to all membrane systems, including those of vascular smooth muscle cells. Third, the results indicate that bilirubin does not act in precisely the same manner as the calcium ionophore A23187 because that agent further increased the uptake of Ca2' by these cells. If bilirubin possesses ionophorelike activity, it may act only at the sarcolemma, whereas the more mobile A23187 will also conduct Ca21 to intramitochondrial binding sites. The solubility characteristics and carboxyl groups of bilirubin render it a negatively charged amphiphile, and part of its action could be similar to that of other negatively charged amphiphiles that have been found to stimulate the Na+-Ca2+ exchanger. 32 In summary, the principal findings of this study are (1) that bilirubin accrues in subarachnoid hematoma, (2) that bilirubin exerts a direct contractile effect on arterial smooth muscle cells, (3) that in these cells it causes an increased uptake of Ca2', and (4) that this increase could be caused by greater permeability of the membrane to Ca 2+, but not to certain other solutes, such as sucrose. The results of this investigation do not eliminate the possibility that the action of bilirubin on whole arteries may also be mediated through the release of vasoactive substances from nerve varicosities or from the endothelium. It is also possible that bilirubin may lead to the release of intracellular Ca21 stores. These issues, as well as the precise role that bilirubin may play in the genesis of cerebral vasospasm, require further study.
